CA2171563A1
(en)
*
|
1993-09-14 |
1995-03-23 |
Eric Le Cheminant |
Injection device
|
CA2551185C
(en)
*
|
1994-03-28 |
2007-10-30 |
Sdgi Holdings, Inc. |
Apparatus and method for anterior spinal stabilization
|
SE9403433D0
(sv)
|
1994-10-10 |
1994-10-10 |
Pharmacia Ab |
Injection device
|
SE9502285D0
(sv)
|
1995-06-22 |
1995-06-22 |
Pharmacia Ab |
Improvements related to injections
|
US6058321A
(en)
*
|
1995-09-07 |
2000-05-02 |
Swayze; Claude R. |
Instrument for continuously monitoring fetal heart rate and intermittently monitoring fetal blood pH and method of use
|
DE59609513D1
(de)
*
|
1996-04-02 |
2002-09-05 |
Disetronic Licensing Ag |
Injektionsgerät
|
DE59609696D1
(de)
|
1996-04-02 |
2002-10-24 |
Disetronic Licensing Ag |
Injektionsgerät
|
ATE251479T1
(de)
|
1996-07-05 |
2003-10-15 |
Disetronic Licensing Ag |
Injektionsgerät zum injizieren von flüssigkeit
|
WO1998001172A1
(de)
*
|
1996-07-05 |
1998-01-15 |
Disetronic Licensing Ag |
Injektionsgerät zum injizieren von flüssigkeit
|
DE19717107B4
(de)
|
1997-04-23 |
2005-06-23 |
Disetronic Licensing Ag |
System aus Behältnis und Antriebsvorrichtung für einen Kolben, der in dem ein Medikamentfluid enthaltenden Behältnis gehalten ist
|
CA2411996C
(en)
|
1997-04-24 |
2009-09-08 |
Ntt Mobile Communications Network Inc. |
Method and system for mobile communications
|
DE19740187C1
(de)
*
|
1997-09-12 |
1999-04-15 |
Disetronic Licensing Ag |
Vorrichtung zur dosierten Ausschüttung eines injizierbaren Produkts
|
US6605058B1
(en)
|
1997-11-17 |
2003-08-12 |
Disetronic Licensing Ag |
Device for introducing a needle
|
DE59811344D1
(de)
|
1997-11-19 |
2004-06-09 |
B D Medico S A R L |
Nadelanordnung
|
US6482176B1
(en)
|
1997-11-27 |
2002-11-19 |
Disetronic Licensing Ag |
Method and device for controlling the introduction depth of an injection needle
|
DE19755125B4
(de)
*
|
1997-12-11 |
2006-04-20 |
Tecpharma Licensing Ag |
Nadelschutzvorrichtung für Injektionsgeräte
|
DK1047343T3
(da)
|
1998-01-12 |
2004-11-01 |
Alsensa Aps |
En injektor
|
US6949111B2
(en)
|
1998-02-13 |
2005-09-27 |
Steven Schraga |
Lancet device
|
US5997509A
(en)
*
|
1998-03-06 |
1999-12-07 |
Cornell Research Foundation, Inc. |
Minimally invasive gene therapy delivery device and method
|
CA2229522A1
(en)
|
1998-04-15 |
1999-10-15 |
Thomas Randall Inkpen |
Needle aid
|
DE19821933C1
(de)
|
1998-05-15 |
1999-11-11 |
Disetronic Licensing Ag |
Vorrichtung zur Verabreichung eines injizierbaren Produkts
|
US6290679B1
(en)
|
1999-05-14 |
2001-09-18 |
Disetronic Licensing Ag |
Device for metered administration of an injectable product
|
DE19822031C2
(de)
|
1998-05-15 |
2000-03-23 |
Disetronic Licensing Ag |
Autoinjektionsgerät
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
DE19925904C1
(de)
|
1999-06-07 |
2001-02-01 |
Disetronic Licensing Ag |
Vorrichtung zur subkutanen Verabreichung eines injizierbaren Produkts
|
US8465468B1
(en)
|
2000-06-29 |
2013-06-18 |
Becton, Dickinson And Company |
Intradermal delivery of substances
|
US6843781B2
(en)
|
1999-10-14 |
2005-01-18 |
Becton, Dickinson And Company |
Intradermal needle
|
US20020095134A1
(en)
*
|
1999-10-14 |
2002-07-18 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
US6776776B2
(en)
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US20020198509A1
(en)
*
|
1999-10-14 |
2002-12-26 |
Mikszta John A. |
Intradermal delivery of vaccines and gene therapeutic agents via microcannula
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US7241275B2
(en)
*
|
1999-10-14 |
2007-07-10 |
Becton, Dickinson And Company |
Intradermal needle
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US6494865B1
(en)
*
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US20020156453A1
(en)
*
|
1999-10-14 |
2002-10-24 |
Pettis Ronald J. |
Method and device for reducing therapeutic dosage
|
US8814896B2
(en)
|
1999-11-02 |
2014-08-26 |
Stat Medical Devices, Inc. |
Single use lancet assembly
|
US20050070945A1
(en)
*
|
1999-11-02 |
2005-03-31 |
Steven Schraga |
Single use lancet assembly
|
US6322575B1
(en)
|
2000-01-05 |
2001-11-27 |
Steven Schraga |
Lancet depth adjustment assembly
|
DE20006251U1
(de)
*
|
2000-04-05 |
2001-08-16 |
B D Medico Gmbh Mies |
Nadelschutzanordnung
|
US6508802B1
(en)
|
2000-05-23 |
2003-01-21 |
Cornell Research Foundation, Inc. |
Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heart
|
US6547764B2
(en)
*
|
2000-05-31 |
2003-04-15 |
Novo Nordisk A/S |
Double pointed injection needle
|
US20050008683A1
(en)
*
|
2000-06-29 |
2005-01-13 |
Becton Dickinson And Company |
Method for delivering interferons to the intradermal compartment
|
US20040175360A1
(en)
*
|
2000-06-29 |
2004-09-09 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
US6986760B2
(en)
*
|
2000-08-02 |
2006-01-17 |
Becton, Dickinson And Company |
Pen needle and safety shield system
|
AU2001280762A1
(en)
|
2000-08-02 |
2002-02-13 |
Becton, Dickinson And Company |
Pen needle and safety shield system
|
DE10044383C2
(de)
*
|
2000-09-08 |
2003-02-06 |
Disetronic Licensing Ag |
Nadelschutzvorrichtung
|
CA2438942A1
(en)
|
2001-02-23 |
2002-09-26 |
Glaxosmithkline Biologicals S.A. |
Influenza vaccine formulations for intradermal delivery
|
CA2438960A1
(en)
*
|
2001-02-23 |
2002-09-06 |
Glaxosmithkline Biologicals S.A. |
Influenza vaccine formulations for intradermal delivery
|
ATE354338T1
(de)
|
2001-03-27 |
2007-03-15 |
Lilly Co Eli |
Kit mit einer spritzennadel mit seitenöffnung zur bereitung eines medikaments in einer injektionsstiftkartusche
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
EP1381423A1
(en)
*
|
2001-04-13 |
2004-01-21 |
Becton, Dickinson and Company |
Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption
|
EP1385560B1
(en)
*
|
2001-04-13 |
2018-05-16 |
Becton, Dickinson and Company |
Prefillable intradermal delivery device with hidden needle and passive shielding
|
EP1381344A4
(en)
*
|
2001-04-27 |
2008-06-11 |
Glaxosmithkline Biolog Sa |
NEW VACCINE
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
MY134424A
(en)
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
AU2002310432A1
(en)
*
|
2001-06-13 |
2003-06-23 |
Steven Schraga |
Single use lancet device
|
US20030073609A1
(en)
*
|
2001-06-29 |
2003-04-17 |
Pinkerton Thomas C. |
Enhanced pharmacokinetic profile of intradermally delivered substances
|
US20060018877A1
(en)
*
|
2001-06-29 |
2006-01-26 |
Mikszta John A |
Intradermal delivery of vacccines and therapeutic agents
|
US20050010193A1
(en)
*
|
2002-05-06 |
2005-01-13 |
Laurent Philippe E. |
Novel methods for administration of drugs and devices useful thereof
|
US6918918B1
(en)
|
2001-08-14 |
2005-07-19 |
Steven Schraga |
Single use lancet assembly
|
US8048097B2
(en)
*
|
2001-08-14 |
2011-11-01 |
Steven Schraga |
Single use lancet assembly
|
US20040120964A1
(en)
*
|
2001-10-29 |
2004-06-24 |
Mikszta John A. |
Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
|
ATE316395T1
(de)
|
2001-11-30 |
2006-02-15 |
Novo Nordisk As |
Nadelsicherheitsvorrichtung
|
US20050033230A1
(en)
*
|
2002-02-15 |
2005-02-10 |
Alchas Paul G. |
Prefillable intradermal delivery device with hidden needle and passive shielding
|
DE10207276A1
(de)
*
|
2002-02-21 |
2003-09-11 |
Disetronic Licensing Ag |
Nadel-Insertionsvorrichtung mit quer bewegbarem Halteelement
|
CH695758A5
(de)
*
|
2002-03-05 |
2006-08-31 |
Tecpharma Licensing Ag |
Kühlvorrichtung für Injektionsgeräte.
|
US8715309B2
(en)
|
2002-04-29 |
2014-05-06 |
Steven Schraga |
Lancet device
|
US20040039407A1
(en)
*
|
2002-04-29 |
2004-02-26 |
Steven Schraga |
Lancet device
|
CN1655834A
(zh)
*
|
2002-05-06 |
2005-08-17 |
贝克顿·迪金森公司 |
用于控制药代动力学的方法和装置
|
US20060264886A9
(en)
*
|
2002-05-06 |
2006-11-23 |
Pettis Ronald J |
Method for altering insulin pharmacokinetics
|
BR0313890A
(pt)
*
|
2002-08-30 |
2005-07-26 |
Becton Dickinson Co |
Método de controle da farmacocinética de compostos imunomoduladores
|
ES2611428T3
(es)
|
2003-01-30 |
2017-05-08 |
Becton, Dickinson And Company |
Dispositivo de aporte intradérmico con geometría superficial contorneada para acoplamiento con la piel
|
CA2526720C
(en)
|
2003-05-22 |
2013-10-22 |
Fraunhofer Usa, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
CA2529048A1
(en)
*
|
2003-06-13 |
2005-02-24 |
Becton, Dickinson And Company |
Improved intra-dermal delivery of biologically active agents
|
US8932264B2
(en)
*
|
2003-08-11 |
2015-01-13 |
Becton, Dickinson And Company |
Medication delivery pen assembly with needle locking safety shield
|
JP3100042U
(ja)
*
|
2003-08-26 |
2004-04-30 |
アルプス電気株式会社 |
テレビジョンチューナ
|
EP1658078A4
(en)
*
|
2003-08-26 |
2009-05-06 |
Becton Dickinson Co |
PROCESS FOR THE INTRADERMAL DISTRIBUTION OF THERAPEUTIC AGENTS
|
CA2536681C
(en)
|
2003-08-28 |
2011-07-05 |
Becton, Dickinson And Company |
Intradermal injection device
|
AU2003270473A1
(en)
*
|
2003-09-09 |
2005-04-27 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
FR2861284B1
(fr)
*
|
2003-10-24 |
2005-12-30 |
Gaetan Terrasse |
Dispositif d'inoculation therapeutique et diagnostique
|
WO2005091922A2
(en)
*
|
2004-03-03 |
2005-10-06 |
Becton, Dickinson And Company |
Methods and devices for improving delivery of a substance to skin
|
WO2005115360A2
(en)
*
|
2004-05-11 |
2005-12-08 |
Becton, Dickinson And Company |
Formulations of anti-pain agents and methods of using the same
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US20060178686A1
(en)
*
|
2005-02-07 |
2006-08-10 |
Steven Schraga |
Single use lancet device
|
TW200700078A
(en)
|
2005-03-23 |
2007-01-01 |
Glaxosmithkline Biolog Sa |
Novel use
|
MX2007012226A
(es)
|
2005-04-04 |
2007-12-10 |
Univ Florida |
Analogos de polieter de desferritiocina.
|
WO2007117264A2
(en)
*
|
2005-08-03 |
2007-10-18 |
Fraunhofer Usa, Inc. |
Compositions and methods for production of immunoglobulins
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
WO2007070682A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
AU2007215080A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Influenza antigens, vaccine compositions, and related methods
|
US8277816B2
(en)
*
|
2006-02-13 |
2012-10-02 |
Fraunhofer Usa, Inc. |
Bacillus anthracis antigens, vaccine compositions, and related methods
|
CA2642056A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Hpv antigens, vaccine compositions, and related methods
|
EP1998684A4
(en)
*
|
2006-03-10 |
2014-09-17 |
Massachusetts Inst Technology |
CONJUGATES AND NANOSYSTEMS WITH TRIGGERED SELF ASSEMBLY
|
WO2007111806A2
(en)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Cyclopentane heptanoic acid compounds for reducing body fat
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
WO2007120638A2
(en)
*
|
2006-04-12 |
2007-10-25 |
President And Fellows Of Harvard College |
Methods and compositions for modulating glycosylation
|
JP5630998B2
(ja)
|
2006-05-15 |
2014-11-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
機能的粒子のためのポリマー
|
CN104356230A
(zh)
|
2006-06-02 |
2015-02-18 |
哈佛大学校长及研究员协会 |
蛋白质表面重建
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
PT2422810E
(pt)
|
2006-07-17 |
2014-12-03 |
Glaxosmithkline Biolog Sa |
Vacina da gripe
|
US9115358B2
(en)
*
|
2006-08-11 |
2015-08-25 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
WO2008021415A2
(en)
*
|
2006-08-14 |
2008-02-21 |
Massachusetts Institute Of Technology |
Glycan data mining system
|
US20090269342A1
(en)
*
|
2006-08-14 |
2009-10-29 |
Massachusetts Institute Of Technology |
Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
|
JO3598B1
(ar)
*
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
US7811254B2
(en)
*
|
2006-10-18 |
2010-10-12 |
Meridian Medical Technologies, Inc. |
Autoinjector with needle depth adapter
|
BRPI0719756A2
(pt)
|
2006-12-01 |
2014-01-21 |
Anterios Inc |
Nanopartículas de entidades anfifílicas
|
WO2008073856A2
(en)
*
|
2006-12-08 |
2008-06-19 |
Massachusetts Institute Of Technology |
Delivery of nanoparticles and/or agents to cells
|
ES2805286T3
(es)
*
|
2006-12-26 |
2021-02-11 |
Lantheus Medical Imaging Inc |
Ligandos para la formación de imágenes de la inervación cardíaca
|
ES2558928T3
(es)
|
2007-01-31 |
2016-02-09 |
Dana-Farber Cancer Institute, Inc. |
Péptidos p53 estabilizados y usos de los mismos
|
US9217129B2
(en)
*
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
CN101687825B
(zh)
|
2007-03-15 |
2014-04-23 |
佛罗里达大学研究基金公司 |
去铁硫辛聚醚类似物
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
US8592377B2
(en)
|
2007-03-28 |
2013-11-26 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
WO2008124639A2
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Poly (amino acid) targeting moieties
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
BRPI0810865A2
(pt)
*
|
2007-04-28 |
2017-05-09 |
Fraunhofer Usa Inc |
antígenos de tripanossoma, composições vacinais, e métodos relacionados
|
PL2175881T3
(pl)
*
|
2007-06-14 |
2012-12-31 |
Crucell Switzerland Ag |
Śródskórna szczepionka przeciwko grypie
|
WO2008156676A1
(en)
|
2007-06-15 |
2008-12-24 |
President And Fellows Of Harvard College |
Methods and compositions for detecting and modulating o-glycosylation
|
EP2178558B1
(en)
|
2007-07-11 |
2014-04-30 |
iBio, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
WO2009026397A2
(en)
*
|
2007-08-20 |
2009-02-26 |
Fraunhofer Usa, Inc. |
Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
|
EP2205074A4
(en)
*
|
2007-10-04 |
2013-07-31 |
Harvard College |
ANALOGUES OF THE MOENOMYCIN, METHODS OF SYNTHESIS AND USES THEREOF
|
EP2630967A1
(en)
|
2007-10-12 |
2013-08-28 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
WO2009089119A2
(en)
*
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
ES2615954T3
(es)
|
2008-03-13 |
2017-06-08 |
Becton, Dickinson And Company |
Conjunto de seguridad de aguja para pluma con protección de los extremos para el paciente y no para el paciente
|
WO2009154826A2
(en)
|
2008-03-13 |
2009-12-23 |
Becton, Dickinson And Company |
Safety pen needle assembly having shield for non-patient end
|
ES2729650T3
(es)
|
2008-03-13 |
2019-11-05 |
Becton Dickinson Co |
Conjunto de aguja de seguridad
|
WO2009126691A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
CA2725601A1
(en)
*
|
2008-04-28 |
2009-11-05 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
KR102080429B1
(ko)
|
2008-06-26 |
2020-02-21 |
안테리오스, 인코퍼레이티드 |
경피 운반
|
JP5986745B2
(ja)
|
2008-07-15 |
2016-09-06 |
アカデミア シニカAcademia Sinica |
Ptfe様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
|
EP2356139A4
(en)
|
2008-07-23 |
2013-01-09 |
Harvard College |
LIGATURE OF STAPLED POLYPEPTIDES
|
EP2317994A4
(en)
*
|
2008-07-23 |
2012-09-12 |
Massachusetts Inst Technology |
ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS DNA DAMAGE AND INCREASES NEURONAL SURVIVAL
|
WO2010037046A1
(en)
|
2008-09-28 |
2010-04-01 |
Fraunhofer Usa, Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
EP2376619A4
(en)
|
2008-12-15 |
2012-07-04 |
Greenlight Biosciences Inc |
METHODS FOR CONTROLLING FLOWS IN METABOLIC PATHWAYS
|
EP2379728A4
(en)
*
|
2008-12-22 |
2016-04-13 |
Greenlight Biosciences Inc |
COMPOSITIONS AND METHOD FOR PRODUCING A COMPOUND
|
CA2757622A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
ES2493916T3
(es)
|
2009-04-07 |
2014-09-12 |
Infinity Pharmaceuticals, Inc. |
Inhibidores de hidrolasa de amida de ácidos grasos
|
WO2010129023A2
(en)
|
2009-04-28 |
2010-11-11 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
JP2012528858A
(ja)
|
2009-06-01 |
2012-11-15 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
O−GlcNAc転移酵素阻害剤およびその使用
|
JP2012532929A
(ja)
|
2009-07-13 |
2012-12-20 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
二機能性のステープリングされたポリペプチドおよびそれらの使用
|
US20130072439A1
(en)
|
2009-09-22 |
2013-03-21 |
Huw M. Nash |
Peptidomimetic macrocycles
|
US8784819B2
(en)
|
2009-09-29 |
2014-07-22 |
Ibio Inc. |
Influenza hemagglutinin antibodies, compositions and related methods
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
EP2937345B1
(en)
|
2009-12-29 |
2018-03-21 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
CA2787940C
(en)
|
2010-01-27 |
2020-01-07 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
WO2011097233A1
(en)
|
2010-02-03 |
2011-08-11 |
Infinity Pharmaceuticals, Inc. |
Fatty acid amide hydrolase inhibitors
|
JP5827962B2
(ja)
|
2010-03-08 |
2015-12-02 |
スローン ケタリング インスティテュート フォア キャンサー リサーチ |
Cdc7キナーゼ阻害剤およびその使用
|
EP2550285B1
(en)
|
2010-03-22 |
2017-07-19 |
President and Fellows of Harvard College |
Trioxacarcins and uses thereof
|
US10338069B2
(en)
|
2010-04-12 |
2019-07-02 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
WO2011140190A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals |
Tetrazolones as inhibitors of fatty acid synthase
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
DK2566953T3
(en)
|
2010-05-07 |
2019-04-15 |
Greenlight Biosciences Inc |
METHODS OF MANAGING THE POWER BY METABOLIC ROADS USING ENZYMOUS LOCATION
|
EP3653230B1
(en)
|
2010-05-11 |
2023-05-10 |
Lantheus Medical Imaging, Inc. |
Compositions, methods and systems for the synthesis and use of imaging agents
|
EP2582836B1
(en)
|
2010-06-18 |
2018-03-07 |
Taiho Pharmaceutical Co., Ltd. |
Prpk-tprkb modulators and uses thereof
|
EP2399631A1
(en)
*
|
2010-06-28 |
2011-12-28 |
Sanofi-Aventis Deutschland GmbH |
Auto-injector with injection damper
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
JP2013535514A
(ja)
|
2010-08-13 |
2013-09-12 |
エイルロン セラピューティクス,インコーポレイテッド |
ペプチド模倣大環状分子
|
EP2611922A1
(en)
|
2010-08-31 |
2013-07-10 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
CA2811023A1
(en)
|
2010-09-21 |
2012-03-29 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
|
US8957026B2
(en)
|
2010-09-22 |
2015-02-17 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
LT3590949T
(lt)
|
2010-10-01 |
2022-07-25 |
Modernatx, Inc. |
Ribonukleorūgštys, kurių sudėtyje yra n1-metil-pseudouracilų, ir jų naudojimas
|
EP2624864B1
(en)
|
2010-10-04 |
2017-12-06 |
Massachusetts Institute of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
CN105601729A
(zh)
*
|
2010-11-09 |
2016-05-25 |
诺沃—诺迪斯克有限公司 |
双-酰化的glp-1衍生物
|
EP2637669A4
(en)
|
2010-11-10 |
2014-04-02 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and their use
|
EP2663309B1
(en)
|
2011-01-10 |
2017-03-15 |
Infinity Pharmaceuticals, Inc. |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
ES2579990T3
(es)
|
2011-01-19 |
2016-08-18 |
Terakine Therapeutics, Inc. |
Métodos y composiciones para tratar el síndrome metabólico
|
KR20140003573A
(ko)
|
2011-01-24 |
2014-01-09 |
안테리오스, 인코퍼레이티드 |
오일 조성물
|
ES2720648T3
(es)
|
2011-01-24 |
2019-07-23 |
Anterios Inc |
Composiciones de nanopartículas
|
SG10201804552WA
(en)
|
2011-01-24 |
2018-07-30 |
Anterios Inc |
Nanoparticle compositions, formulations thereof, and uses therefor
|
WO2012119078A2
(en)
|
2011-03-03 |
2012-09-07 |
Tersus Pharmaceuticals, LLC |
COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE
|
WO2012135615A2
(en)
|
2011-03-30 |
2012-10-04 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
EP2734520B1
(en)
|
2011-07-19 |
2016-09-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CA2842190A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
EP2734510B8
(en)
|
2011-07-22 |
2019-05-29 |
Massachusetts Institute of Technology |
Activators of class i histone deacetylases (hdacs) and uses thereof
|
RU2014111823A
(ru)
|
2011-08-29 |
2015-10-10 |
Инфинити Фармасьютикалз, Инк. |
Гетероциклические соединения и их применения
|
US9469861B2
(en)
|
2011-09-09 |
2016-10-18 |
Greenlight Biosciences, Inc. |
Cell-free preparation of carbapenems
|
CN104159890B
(zh)
|
2011-09-09 |
2018-04-10 |
蓝瑟斯医学影像公司 |
用于合成和使用显像剂的组合物、方法和***
|
WO2013039861A2
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
WO2013049332A1
(en)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
MX354267B
(es)
|
2011-10-03 |
2018-02-21 |
Moderna Therapeutics Inc Star |
Nucléosidos, nucleótidos, y ácidos nucleicos modificados, y usos de los mismos.
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
EP3569598A1
(en)
|
2011-11-17 |
2019-11-20 |
Dana Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
EP2790697B1
(en)
|
2011-12-16 |
2019-10-23 |
University of Florida Research Foundation, Inc. |
Uses of 4'-desferrithiocin analogs
|
US20130156849A1
(en)
|
2011-12-16 |
2013-06-20 |
modeRNA Therapeutics |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
CN104159595A
(zh)
|
2012-02-15 |
2014-11-19 |
爱勒让治疗公司 |
拟肽大环化合物
|
WO2013123267A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
US10106833B2
(en)
|
2012-04-06 |
2018-10-23 |
President And Fellows Of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
WO2013152277A2
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
WO2013152279A1
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
KR102122618B1
(ko)
|
2012-05-10 |
2020-06-29 |
메사츄세츠 인스티튜트 어브 테크놀로지 |
인플루엔자 중화를 위한 작용제
|
JP2015525794A
(ja)
|
2012-08-06 |
2015-09-07 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
乳児においてrsv及び百日咳菌に対する免疫応答を惹起するための方法
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
US9914956B2
(en)
|
2012-08-18 |
2018-03-13 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
RS61957B1
(sr)
|
2012-09-26 |
2021-07-30 |
Harvard College |
Uvezani peptidi blokirani prolinom i njihove upotrebe
|
WO2014055564A1
(en)
|
2012-10-01 |
2014-04-10 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
CA2887701C
(en)
|
2012-10-12 |
2020-12-15 |
The Broad Institute, Inc. |
Gsk3 inhibitors and methods of use thereof
|
US10112927B2
(en)
|
2012-10-18 |
2018-10-30 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
WO2014063054A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
|
WO2014063061A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
MX2015005244A
(es)
|
2012-11-01 |
2015-07-14 |
Aileron Therapeutics Inc |
Aminoacidos disustituidos y metodos de preparacion y el uso de los mismos.
|
TR201812261T4
(tr)
|
2012-11-01 |
2018-11-21 |
Infinity Pharmaceuticals Inc |
Pi3 ki̇naz i̇zoform modülatörleri̇ i̇le kanser tedavi̇si̇
|
WO2014071247A1
(en)
|
2012-11-02 |
2014-05-08 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
|
MX2015006390A
(es)
|
2012-11-21 |
2015-08-05 |
Topokine Therapeutics Inc |
Metodos y composiciones para incrementar localmente la grasa corporal.
|
JP6408478B2
(ja)
|
2012-11-26 |
2018-10-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
|
HRP20220607T1
(hr)
|
2012-11-26 |
2022-06-24 |
Modernatx, Inc. |
Terminalno modificirana rna
|
JP2016505001A
(ja)
|
2012-12-21 |
2016-02-18 |
エピザイム,インコーポレイティド |
Prmt5阻害剤およびその使用
|
US8906900B2
(en)
|
2012-12-21 |
2014-12-09 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
JP2016505002A
(ja)
|
2012-12-21 |
2016-02-18 |
エピザイム,インコーポレイティド |
ジヒドロイソキノリンまたはテトラヒドロイソキノリンを含有するprmt5阻害剤およびその使用
|
PE20151501A1
(es)
|
2012-12-21 |
2015-11-08 |
Epizyme Inc |
Inhibidores de prmt5 y sus usos
|
EP2946014A2
(en)
|
2013-01-17 |
2015-11-25 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
CA2900008A1
(en)
|
2013-02-07 |
2014-08-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
WO2014124319A2
(en)
|
2013-02-07 |
2014-08-14 |
Massachusetts Institute Of Technology |
Human adaptation of h5 influenza
|
BR112015022872A2
(pt)
|
2013-03-13 |
2017-11-07 |
Harvard College |
polipeptídeos grampeados e costurados, seu uso, seu método de preparação, composição que os compreende e aminoácido
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
NZ629037A
(en)
|
2013-03-15 |
2017-04-28 |
Infinity Pharmaceuticals Inc |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
US9539217B2
(en)
|
2013-04-03 |
2017-01-10 |
Allertein Therapeutics, Llc |
Nanoparticle compositions
|
BR112015025159A2
(pt)
|
2013-04-04 |
2017-07-18 |
Harvard College |
macrolídeos e métodos de sua preparação e uso
|
ES2774330T3
(es)
|
2013-04-09 |
2020-07-20 |
Massachusetts Inst Technology |
Polímero de suministro de fármaco y usos del mismo
|
WO2014179464A1
(en)
|
2013-04-30 |
2014-11-06 |
Massachusetts Institute Of Technology |
Human adaptation of h3 influenza
|
US9315472B2
(en)
|
2013-05-01 |
2016-04-19 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(es)
|
2013-05-10 |
2018-06-16 |
|
|
WO2014194254A1
(en)
|
2013-05-30 |
2014-12-04 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
WO2014197723A2
(en)
|
2013-06-05 |
2014-12-11 |
Massachusetts Institute Of Technology |
Human adaptation of h7 ha
|
CA2914815A1
(en)
|
2013-06-11 |
2014-12-18 |
Kala Pharmaceuticals, Inc. |
Urea derivatives and uses thereof
|
WO2014201370A1
(en)
|
2013-06-14 |
2014-12-18 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
EP3013347B1
(en)
|
2013-06-27 |
2019-12-11 |
Academia Sinica |
Glycan conjugates and use thereof
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
BR112016002494A2
(pt)
|
2013-08-05 |
2017-09-05 |
Greenlight Biosciences Inc |
Proteí-nas construídas com um sítio de clivagem de protease, ácido nucléico, vetor, célula e processo de engenharia de uma proteína recombinante e de um grande número de variantes de ácidos nucleicos que codificam proteínas recombinantes
|
US20160193322A1
(en)
|
2013-08-05 |
2016-07-07 |
Glaxosmithkline Biologicals S.A. |
Combination immunogenic compositions
|
CN105682666B
(zh)
|
2013-09-06 |
2021-06-01 |
中央研究院 |
使用醣脂激活人类iNKT细胞
|
US9550744B2
(en)
|
2013-09-25 |
2017-01-24 |
University Of Florida Research Foundation, Inc. |
Vitamin C prodrugs and uses thereof
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
HUE057734T2
(hu)
|
2013-10-04 |
2022-06-28 |
Infinity Pharmaceuticals Inc |
Heterociklusos vegyületek és alkalmazásuk
|
WO2015057894A1
(en)
|
2013-10-15 |
2015-04-23 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
US9902986B2
(en)
|
2013-10-16 |
2018-02-27 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
CN105849099B
(zh)
|
2013-10-18 |
2020-01-17 |
达纳-法伯癌症研究所股份有限公司 |
周期蛋白依赖性激酶7(cdk7)的多环抑制剂
|
AU2014337122B2
(en)
|
2013-10-18 |
2019-01-03 |
Dana-Farber Cancer Institute, Inc. |
Heteroaromatic compounds useful for the treatment of proliferative diseases
|
WO2015061204A1
(en)
|
2013-10-21 |
2015-04-30 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CN106061261B
(zh)
|
2013-11-01 |
2018-04-24 |
卡拉制药公司 |
治疗化合物的结晶形式及其用途
|
CA2873770A1
(en)
|
2013-12-10 |
2015-06-10 |
Becton, Dickinson And Company |
Active safety pen needle assembly
|
EP2883562B1
(en)
|
2013-12-10 |
2016-08-17 |
Becton Dickinson and Company |
Passive safety pen needle assembly
|
CA2934819A1
(en)
|
2013-12-24 |
2015-07-02 |
President And Fellows Of Harvard College |
Cortistatin analogues and syntheses and uses thereof
|
CN106459920B
(zh)
|
2014-01-16 |
2020-10-30 |
中央研究院 |
治疗及检测癌症的组合物及方法
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
AU2015226911B2
(en)
|
2014-03-07 |
2018-03-01 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain
|
CN106456628A
(zh)
|
2014-03-19 |
2017-02-22 |
无限药品股份有限公司 |
用于治疗PI3K‑γ介导的障碍的杂环化合物
|
JP6562942B2
(ja)
|
2014-03-27 |
2019-08-28 |
アカデミア シニカAcademia Sinica |
反応性標識化合物およびその使用
|
ES2868305T3
(es)
|
2014-03-28 |
2021-10-21 |
Univ Washington Through Its Center For Commercialization |
Vacunas contra el cáncer de mama y de ovario
|
US9862688B2
(en)
|
2014-04-23 |
2018-01-09 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
WO2015164614A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
US10039816B2
(en)
|
2014-04-30 |
2018-08-07 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
EP3145523A4
(en)
|
2014-05-21 |
2018-02-21 |
President and Fellows of Harvard College |
Ras inhibitory peptides and uses thereof
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
EP4116329A1
(en)
|
2014-05-27 |
2023-01-11 |
Academia Sinica |
Anti-her2 glycoantibodies and uses thereof
|
CN106661562A
(zh)
|
2014-05-27 |
2017-05-10 |
中央研究院 |
得自类杆菌属的岩藻糖苷酶及其用途
|
CA2950415A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
KR102494193B1
(ko)
|
2014-05-28 |
2023-01-31 |
아카데미아 시니카 |
항-tnf-알파 글리코항체 및 이의 용도
|
CA2951430A1
(en)
|
2014-06-13 |
2015-12-17 |
Glaxosmithkline Biologicals Sa |
Immunogenic combinations
|
CN106559991B
(zh)
|
2014-06-19 |
2019-09-20 |
阿里亚德医药股份有限公司 |
用于激酶抑制的杂芳基化合物
|
US10188661B2
(en)
|
2014-06-27 |
2019-01-29 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
WO2016004202A1
(en)
|
2014-07-02 |
2016-01-07 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
US10759836B2
(en)
|
2014-07-18 |
2020-09-01 |
University Of Washington |
Cancer vaccine compositions and methods of use thereof
|
WO2016025643A1
(en)
|
2014-08-12 |
2016-02-18 |
Massachusetts Institute Of Technology |
Brush-poly(glycoamidoamine)-lipids and uses thereof
|
JP6899321B2
(ja)
|
2014-09-08 |
2021-07-07 |
アカデミア シニカAcademia Sinica |
糖脂質を使用するヒトiNKT細胞活性化
|
AU2015320549A1
(en)
|
2014-09-24 |
2017-04-13 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
JP2018503595A
(ja)
|
2014-09-24 |
2018-02-08 |
エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. |
ペプチド模倣大環状分子およびその製剤
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
SG11201702980QA
(en)
|
2014-10-21 |
2017-05-30 |
Ariad Pharma Inc |
Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] pyrimidine-2,4-diamine
|
US20180015101A1
(en)
|
2014-10-28 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions and methods for antigen-specific tolerance
|
EP3041948B1
(en)
|
2014-11-10 |
2019-01-09 |
Modernatx, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
WO2016086026A1
(en)
|
2014-11-26 |
2016-06-02 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
CA2969467A1
(en)
|
2014-12-10 |
2016-06-16 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
|
JP2017538731A
(ja)
|
2014-12-18 |
2017-12-28 |
ウィンドギャップ メディカル, インコーポレイテッド |
治療剤を溶解または可溶化するための方法および組成物。
|
EP3236959A4
(en)
|
2014-12-23 |
2018-04-25 |
Dana Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
CA2972266C
(en)
|
2014-12-23 |
2023-05-09 |
Sloan-Kettering Institute For Cancer Research |
Polymorph of granaticin b
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
KR20170104617A
(ko)
|
2015-01-24 |
2017-09-15 |
아카데미아 시니카 |
신규한 글리칸 콘주게이트 및 이를 사용하는 방법
|
BR112017019738A2
(pt)
|
2015-03-20 |
2018-05-29 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos e usos dos mesmos
|
WO2016160617A2
(en)
|
2015-03-27 |
2016-10-06 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
KR20180002636A
(ko)
|
2015-03-30 |
2018-01-08 |
그린라이트 바이오사이언시스, 아이엔씨. |
리보핵산의 무세포 생산
|
EP3288557A4
(en)
|
2015-04-27 |
2018-11-07 |
University of Florida Research Foundation, Inc. |
Metabolically programmed metal chelators and uses thereof
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
CA2986441A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
CA2990172A1
(en)
|
2015-06-19 |
2016-12-22 |
Massachusetts Institute Of Technology |
Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
EP4019515A1
(en)
|
2015-09-09 |
2022-06-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
US10023613B2
(en)
|
2015-09-10 |
2018-07-17 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of MCL-1
|
EP3350157B1
(en)
|
2015-09-17 |
2022-01-05 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
JP2018527003A
(ja)
|
2015-09-17 |
2018-09-20 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
安定化尾部領域を含むポリヌクレオチド
|
US9925170B2
(en)
|
2015-10-01 |
2018-03-27 |
Kythera Biopharmaceuticals, Inc. |
Methods of adipolysis and compositions useful therein
|
JPWO2017073658A1
(ja)
*
|
2015-10-30 |
2018-08-30 |
テルモ株式会社 |
グリップ及び注射器組立体
|
JP7114465B2
(ja)
|
2015-12-22 |
2022-08-08 |
モデルナティエックス インコーポレイテッド |
薬剤の細胞内送達のための化合物および組成物
|
USD806246S1
(en)
|
2016-02-25 |
2017-12-26 |
Steven Schraga |
Lancet cover
|
CA3016170A1
(en)
|
2016-03-08 |
2017-09-14 |
Academia Sinica |
Methods for modular synthesis of n-glycans and arrays thereof
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
KR20230079463A
(ko)
|
2016-04-06 |
2023-06-07 |
그린라이트 바이오사이언시스, 아이엔씨. |
리보핵산의 무세포 생산
|
EP3464327A1
(en)
|
2016-06-03 |
2019-04-10 |
Sanofi Pasteur Inc. |
Modification of engineered influenza hemagglutinin polypeptides
|
US10105449B2
(en)
|
2016-06-07 |
2018-10-23 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
US10919914B2
(en)
|
2016-06-08 |
2021-02-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
EP3468537A1
(en)
|
2016-06-14 |
2019-04-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
IL264552B2
(en)
|
2016-08-05 |
2023-04-01 |
Sanofi Pasteur Inc |
A multivalent pneumococcal protein-polysaccharide conjugate preparation
|
KR102467074B1
(ko)
|
2016-08-05 |
2022-11-11 |
사노피 파스퇴르 인코포레이티드 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR102588027B1
(ko)
|
2016-08-22 |
2023-10-12 |
초 파마 인크. |
항체, 결합 단편 및 사용 방법
|
US20180085555A1
(en)
*
|
2016-09-26 |
2018-03-29 |
Boston Scientific Scimed, Inc. |
Injection catheter
|
WO2018089540A1
(en)
|
2016-11-08 |
2018-05-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
KR102487144B1
(ko)
|
2016-11-21 |
2023-01-12 |
에이리온 테라퓨틱스, 인코포레이티드 |
큰 물질의 경피 전달
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
SG11201907916TA
(en)
|
2017-03-15 |
2019-09-27 |
Modernatx Inc |
Compounds and compositions for intracellular delivery of therapeutic agents
|
AU2018234828A1
(en)
|
2017-03-15 |
2019-09-19 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
US11555031B2
(en)
|
2017-03-20 |
2023-01-17 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
WO2018187630A1
(en)
|
2017-04-05 |
2018-10-11 |
The Broad Institute, Inc. |
Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof
|
EP3638678A1
(en)
|
2017-06-14 |
2020-04-22 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS AND USES THEREOF
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS
|
MX2020002348A
(es)
|
2017-08-31 |
2020-10-08 |
Modernatx Inc |
Métodos de elaboración de nanopartículas lipídicas.
|
KR20230130144A
(ko)
|
2017-10-11 |
2023-09-11 |
그린라이트 바이오사이언시스, 아이엔씨. |
뉴클레오시드 트리포스페이트 및 리보핵산 생산을 위한 방법 및 조성물
|
US11786477B2
(en)
|
2017-12-01 |
2023-10-17 |
North Carolina State University |
Fibrin particles and methods of making the same
|
CN113056269A
(zh)
|
2018-09-13 |
2021-06-29 |
艾里奥治疗公司 |
纤溶酶原激活物抑制剂1(pai-1)抑制剂的用途
|
CN113056268A
(zh)
|
2018-09-13 |
2021-06-29 |
艾里奥治疗公司 |
纤溶酶原激活物抑制剂1(pai-1)抑制剂和其用途
|
US20220409536A1
(en)
|
2018-09-19 |
2022-12-29 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
KR20210102301A
(ko)
|
2018-12-03 |
2021-08-19 |
에이리온 테라퓨틱스, 인코포레이티드 |
고분자 제제의 전달 개선
|
EP3911644A1
(en)
|
2019-01-16 |
2021-11-24 |
Curza Global LLC |
Antimicrobial compounds and methods
|
CA3126798A1
(en)
|
2019-01-16 |
2020-07-23 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
EP3917503B1
(en)
|
2019-01-31 |
2024-05-08 |
ModernaTX, Inc. |
Methods of preparing lipid nanoparticles
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
SG11202110518XA
(en)
|
2019-05-14 |
2021-10-28 |
Eirion Therapeutics Inc |
Delaying peak effect and/or extending duration of response
|
CN110236781B
(zh)
*
|
2019-06-13 |
2021-06-29 |
南京医科大学眼科医院 |
一次性无菌可调节用治疗针
|
US20220280639A1
(en)
|
2019-07-31 |
2022-09-08 |
Modernatx, Inc. |
Compositions and methods for delivery of rna interference agents to immune cells
|
EP4003410A1
(en)
|
2019-07-31 |
2022-06-01 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
CA3158103A1
(en)
|
2019-11-13 |
2021-05-20 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
KR20220133957A
(ko)
|
2020-01-31 |
2022-10-05 |
모더나티엑스, 인크. |
지질 나노입자의 제조 방법
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
CN116710116A
(zh)
|
2020-10-30 |
2023-09-05 |
Xeno-Interface株式会社 |
β折叠股桥肽
|
WO2022092294A1
(ja)
|
2020-10-30 |
2022-05-05 |
学校法人慶應義塾 |
サルコペニア関連疾患等の新規治療および予防
|
TW202237068A
(zh)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
製備脂質奈米顆粒的高通量方法及其用途
|
EP4305088A1
(en)
|
2021-03-09 |
2024-01-17 |
Massachusetts Institute of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
WO2023059857A1
(en)
|
2021-10-08 |
2023-04-13 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
WO2023081798A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
CA3237139A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
WO2023114889A1
(en)
|
2021-12-16 |
2023-06-22 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticles
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023172592A1
(en)
*
|
2022-03-11 |
2023-09-14 |
Amgen Inc. |
Adjustable depth autoinjector
|
WO2023177577A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|
WO2024091918A2
(en)
|
2022-10-25 |
2024-05-02 |
Modernatx, Inc. |
Methods of lipid nanoparticle production in cross-mixers
|